Skip to main navigation
Skip to search
Skip to main content
University of Edinburgh Research Explorer Home
Help & FAQ
Home
Research output
Profiles
Research units
Projects
Datasets
Prizes
Activities
Press/Media
Equipment
Search by expertise, name or affiliation
The cardiovascular effects of apelin in vivo in man
Newby, David
(Principal Investigator)
Deanery of Clinical Sciences
Centre for Cardiovascular Science
Overview
Fingerprint
Research output
(2)
Project Details
Status
Finished
Effective start/end date
1/11/06
→
31/10/08
Funding
UK-based charities:
£112,327.00
View all
View less
Fingerprint
Explore the research topics touched on by this project. These labels are generated based on the underlying awards/grants. Together they form a unique fingerprint.
Apelin
Pharmacology, Toxicology and Pharmaceutical Science
100%
Chronic Kidney Failure
Pharmacology, Toxicology and Pharmaceutical Science
58%
Cardiovascular Disease
Pharmacology, Toxicology and Pharmaceutical Science
57%
Chronic Kidney Disease
Medicine and Dentistry
50%
Kidney Function
Medicine and Dentistry
50%
Apelin Receptor
Pharmacology, Toxicology and Pharmaceutical Science
32%
Diseases
Pharmacology, Toxicology and Pharmaceutical Science
16%
Normal Human
Pharmacology, Toxicology and Pharmaceutical Science
10%
Research output
Research output per year
2022
2022
2023
2023
2
Article
Research output per year
Research output per year
Targeting the apelin system for the treatment of cardiovascular diseases
Chapman, F. A.
,
Maguire, J. J.
,
Newby, D. E.
,
Davenport, A. P.
&
Dhaun, N.
,
13 Nov 2023
,
In:
Cardiovascular Research.
119
,
17
,
p. 2683–2696
Research output
:
Contribution to journal
›
Article
›
peer-review
Open Access
File
Cardiovascular Disease
100%
Apelin
100%
Apelin Receptor
50%
Diseases
33%
Anti-Inflammatory Drug
16%
Apelin is expressed throughout the human kidney, is elevated in chronic kidney disease & associates independently with decline in kidney function
Nyimanu, D.
,
Chapman, F. A.
,
Gallacher, P. J.
,
Kuc, R. E.
,
Williams, T. L.
,
Newby, D. E.
,
Maguire, J. J.
,
Davenport, A. P.
&
Dhaun, N.
,
24 Jun 2022
,
In:
British Journal of Clinical Pharmacology.
Research output
:
Contribution to journal
›
Article
›
peer-review
Open Access
File
Kidney Function
100%
Apelin
100%
Chronic Kidney Disease
100%
Chronic Kidney Failure
100%
Normal Human
21%